Afya (NASDAQ:AFYA) Price Target Cut to $18.00 by Analysts at Credit Suisse Group

Afya (NASDAQ:AFYAGet Rating) had its price objective cut by Credit Suisse Group from $19.00 to $18.00 in a report issued on Tuesday morning, Marketbeat reports. They currently have an outperform rating on the stock.

A number of other equities research analysts have also commented on AFYA. TheStreet upgraded Afya from a d+ rating to a c rating in a research report on Friday, September 9th. The Goldman Sachs Group upped their target price on Afya from $12.00 to $13.50 in a research report on Tuesday, September 6th.

Afya Price Performance

Shares of AFYA stock opened at $14.59 on Tuesday. Afya has a fifty-two week low of $8.73 and a fifty-two week high of $17.02. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 20.84, a PEG ratio of 0.43 and a beta of 0.88. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.31 and a current ratio of 1.33. The stock’s 50-day simple moving average is $14.48 and its 200-day simple moving average is $12.41.

Afya (NASDAQ:AFYAGet Rating) last issued its earnings results on Monday, August 22nd. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.04. The firm had revenue of $121.93 million for the quarter, compared to analyst estimates of $119.45 million. Afya had a return on equity of 10.99% and a net margin of 15.67%. As a group, equities analysts forecast that Afya will post 0.97 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. TimesSquare Capital Management LLC lifted its holdings in Afya by 18.9% in the second quarter. TimesSquare Capital Management LLC now owns 1,427,200 shares of the company’s stock valued at $14,201,000 after acquiring an additional 227,100 shares during the period. Russell Investments Group Ltd. lifted its holdings in Afya by 0.7% in the second quarter. Russell Investments Group Ltd. now owns 1,279,944 shares of the company’s stock valued at $12,733,000 after acquiring an additional 8,694 shares during the period. JPMorgan Chase & Co. acquired a new position in Afya in the first quarter valued at approximately $14,949,000. Pendal Group Ltd raised its stake in shares of Afya by 4.8% during the 3rd quarter. Pendal Group Ltd now owns 960,439 shares of the company’s stock worth $13,024,000 after buying an additional 43,651 shares during the period. Finally, BlackRock Inc. raised its stake in shares of Afya by 5.6% during the 3rd quarter. BlackRock Inc. now owns 909,873 shares of the company’s stock worth $12,338,000 after buying an additional 48,047 shares during the period. 60.45% of the stock is owned by institutional investors and hedge funds.

About Afya

(Get Rating)

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments.

Featured Stories

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with's FREE daily email newsletter.